Analyst consensus rating
Privia Health Group Analyst Rating: Strong Buy
PRVA is rated Strong Buy by 18 analysts with a $31.67 target. As of 2026-08-19.
Direct answer
Privia Health Group's consensus rating is Strong Buy.
18 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.67.
Forecast evidence checked August 19, 2026.
Get free Privia Health Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.45
- Average price target
- $31.67
- High price target
- $40.00
- Low price target
- $24.00
- Low target gap
- +11.9%
- Target upside
- +47.6%
- High target gap
- +86.5%
- Target range width
- 74.6%
- Consensus rating
- Strong Buy
- Analysts
- 18
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Privia Health Group?
Privia Health Group has a verified Strong Buy consensus. The same dataset has an average price target of $31.67.
How far are Privia Health Group's low and high targets from the recorded price?
The low target implies +11.9%, while the high target implies +86.5%.
How many analysts are included in Privia Health Group's consensus?
The verified consensus includes 18 analysts.
How is Privia Health Group's target upside or downside calculated?
The average target of $31.67 is divided by the recorded price of $21.45, then one is subtracted to produce +47.6%. This does not guarantee a future return.
When was Privia Health Group's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.